BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2025 7:42:32 AM | Browse: 82 | Download: 188
 |
Received |
|
2025-02-26 10:47 |
|
Peer-Review Started |
|
2025-02-26 10:48 |
|
First Decision by Editorial Office Director |
|
2025-04-03 08:49 |
|
Return for Revision |
|
2025-04-03 08:49 |
|
Revised |
|
2025-04-29 11:10 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-06-16 02:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-06-16 09:20 |
|
Articles in Press |
|
2025-06-16 09:20 |
|
Edit the Manuscript by Language Editor |
|
2025-06-22 20:59 |
|
Typeset the Manuscript |
|
2025-10-08 09:13 |
|
Publish the Manuscript Online |
|
2025-10-14 07:42 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
MEX3A promotes hepatocellular carcinoma cell proliferation and migration via the Wnt/β-catenin and EMT pathways
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Fan-Kai Xiao, Ping Li, Xin-Min Li and Yin Mi |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Youth Foundation of He’nan Scientific Committee |
202300410416 |
| Henan Province Medical Science, Technology Breakthrough Plan Project |
LHGJ20190033 |
|
| Corresponding Author |
Fan-Kai Xiao, Associate Professor, MD, PhD, oncology, first affiliated hospital of zhengzhou university, No,1 jianshe Rd, Zhengzhou China, Zhengzhou 450052, Henan Province, China. xfkw@hotmail.com |
| Key Words |
MEX3A; Hepatocellular carcinoma; Epithelial-mesenchymal transition; Biomarker; Proliferation; Migration |
| Core Tip |
This letter analysis of The Cancer Genome Atlas data revealed that MEX3A mRNA expression is significantly higher in hepatocellular carcinoma (HCC) tissues compared to adjacent non-tumor tissues. High MEX3A expression was associated with worse overall survival in HCC patients. Knockdown of MEX3A in HCC cell lines (HepG2 and MHCC-97H) significantly inhibited cell proliferation and colony formation. MEX3A silencing induced cell cycle arrest at the G1 phase, accompanied by decreased expression of cyclin D1 and increased expression of p21, a cell cycle inhibitor. MEX3A knockdown reduced the nuclear translocation of β-catenin (P < 0.05), a key component of the Wnt signaling pathway, and downregulated downstream targets such as c-Myc and cyclin D1. The development of treatments targeting genes with oncogenic alterations and related signaling pathways, based on advances in understanding of molecular cancer biology, was a major step in cancer treatment evolution. |
| Publish Date |
2025-10-14 07:42 |
| Citation |
Xiao FK, Li P, Li XM, Mi Y. MEX3A promotes hepatocellular carcinoma cell proliferation and migration via the Wnt/β-catenin and EMT pathways. World J Gastrointest Oncol 2025; 17(10): 106410 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i10/106410.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i10.106410 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
